Cubica Pharmaceuticals (003020.SZ): Two products are expected to be selected for the national organizations centralized bulk procurement of medicines.

Zhion Finance APP reported that Cubic Pharmaceutical (003020.SZ) announced that it recently participated in the application for the national organized centralized volume-based procurement of drugs (the 12th batch). According to the "Public Announcement of the Proposed Selected Results for the 12th Batch of National Organized Centralized Volume-Based Procurement" released by the National Organized Drug Procurement Office on July 31, 2026, some of the company's products are proposed for selection in this volume-based procurement. The relevant products include: Doxazosin Mesylate Sustained-Release Tablets and Amiasartan Potassium Tablets.